# US 2016/0250241 A1 · Nicotinamide riboside compositions for topical use in treating skin conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250241 A1
- Document ID: US20160250241A1
- Status: Published application
- Kind: A1
- Application number: 15/033,285
- Filed: 2014-10-30
- Published: 2016-09-01
- Earliest claimed: 2013-10-30
- Assignees: ChromaDex Inc.
- Applicants: Chromadex Inc.
- Inventors: Ann Deren-Lewis; Troy Rhonemus
- Web page: https://patentgrep.com/patent/US20160250241A1

## CPC

- A61K 31/706: containing six-membered rings with nitrogen as a ring hetero atom
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

## Claims

### Claim 1

A chemoprotective method for treating or preventing UV-mediated DNA damage in the skin of an individual comprising topically administering to the individual in need of such treatment a therapeutically effective amount of the compound nicotinamide riboside, or a salt thereof.

### Claim 2 (depends on 1)

The chemoprotective method of claim 1, wherein the individual is a human.

### Claim 3 (depends on 2)

The chemoprotective method of claim 2, wherein the nicotinamide riboside compound, or a salt thereof, is provided in a composition comprising a pharmaceutically acceptable carrier.

### Claim 4 (depends on 3)

The chemoprotective method of claim 3, wherein the nicotinamide riboside compound is a salt selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, ascorbate, benzoate, carbonate, citrate, carbamate, formate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfate, and trifluoroacetate.

### Claim 5 (depends on 4)

The chemoprotective method of claim 4, wherein the nicotinamide riboside compound is a chloride salt.

### Claim 6 (depends on 3)

The chemoprotective method of claim 3, wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.01% by weight to about 50% by weight based on the total weight of the composition.

### Claim 7 (depends on 3)

The chemoprotective method of claim 3, wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.1% by weight to about 10% by weight based on the total weight of the composition.

### Claim 8 (depends on 1)

The chemoprotective method of claim 1, wherein DNA damage indicated by formation of cyclobutane-pyrimidine dimers (CPDs) or 6-4 photoproducts (64 pps) is decreased by greater than about 10%.

### Claim 9

A cytoprotective method for treating or preventing oxidative damage in the skin of an individual comprising topically administering to the individual in need of such treatment a therapeutically effective amount of the compound nicotinamide riboside, or a salt thereof.

### Claim 10 (depends on 9)

The cytoprotective method of claim 9, wherein the individual is a human.

### Claim 11 (depends on 10)

The cytoprotective method of claim 10, wherein the nicotinamide riboside compound, or a salt thereof, is provided in a composition comprising a pharmaceutically acceptable carrier.

### Claim 12 (depends on 11)

The cytoprotective method of claim 11, wherein the nicotinamide riboside compound is a salt selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, ascorbate, benzoate, carbonate, citrate, carbamate, formate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfate, and trifluoroacetate.

### Claim 13 (depends on 12)

The cytoprotective method of claim 12, wherein the nicotinamide riboside compound is a chloride salt.

### Claim 14 (depends on 11)

The cytoprotective method of claim 11, wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.01% by weight to about 50% by weight based on the total weight of the composition.

### Claim 15 (depends on 11)

The cytoprotective method of claim 11, wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.1% by weight to about 10% by weight based on the total weight of the composition.

### Claim 16 (depends on 9)

The cytoprotective method of claim 9, wherein cell death is decreased by greater than about 10%.

### Claim 17

A method for treating or repairing a wound in the skin of an individual, comprising topically administering to the individual in need of such treatment a therapeutically effective amount of the compound nicotinamide riboside, or a salt thereof, wherein skin cells in the skin have increased motility and/or proliferation.

### Claim 18 (depends on 17)

The method of claim 17, wherein the individual is a human.

### Claim 19 (depends on 18)

The method of claim 18, wherein the nicotinamide riboside compound, or a salt thereof, is provided in a composition comprising a pharmaceutically acceptable carrier.

### Claim 20 (depends on 19)

The method of claim 19, wherein the nicotinamide riboside compound is a salt selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, ascorbate, benzoate, carbonate, citrate, carbamate, formate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfate, and trifluoroacetate.

### Claim 21 (depends on 20)

The method of claim 20, wherein the nicotinamide riboside compound is a chloride salt.

### Claim 22 (depends on 19)

The method of claim 19, wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.01% by weight to about 50% by weight based on the total weight of the composition.
